Risk Factors and Prognosis of Carbapenem-Resistant Organism Colonization and Infection in Acute Cholangitis

Overview

Journal Infect Drug Resist

Publisher Dove Medical Press

Date 2023 Jan 4

PMID 36597450

Authors

Kaili Li

Sanle Jiang

Hongxue Fu

Yingting Hao

Shijing Tian

Fachun Zhou

Affiliations

Soon will be listed here.

Abstract

Background: To identify the risk factors and prognosis of carbapenem-resistant organisms (CRO) in patients with acute cholangitis.

Methods: This retrospective observational study was conducted to explore the risk factors and prognosis of CRO infection in 503 acute cholangitis patients diagnosed between July 2013 and January 2022 at the First Affiliated Hospital of Chongqing Medical University, who were divided into a CRO group and non-CRO group based on the presence or absence of CRO. Univariate, multivariate analyses, and the proportional hazards model were used to compare the risk factors and prognosis of CRO suffering in patients with acute cholangitis.

Results: We identified 35 patients colonized with CRO from 503 acute cholangitis patients. In the multivariate analysis, tumor (OR=7.09, 95% CI=1.11-45.30, =0.038) and chronic kidney disease (OR=8.70, 95% CI=2.11-35.88, =0.003) were ascertained as the risk factors of the occurrence on CRO infection under the background of acute cholangitis. CRO infection was identified as an independent risk factor for acute cholangitis patient death (HR=5.147, 95% CI=1.475-17.595, =0.01) by Cox proportional-hazards regression.

Conclusion: Tumor and chronic kidney disease may be risk factors for CRO infection. Patients diagnosed with acute cholangitis further infected with CRO had a poor prognosis and a more severe mortality. Active screening for CRO is expected to facilitate early prevention, diagnosis, and treatment of high-risk patients.

Citing Articles

Comparative Analysis of Microbial Species and Multidrug Resistance Patterns in Acute Cholangitis Patients with Cholecystectomy: A Single-Center Study.

Miutescu B, Vuletici D, Burciu C, Bende F, Ratiu I, Moga T Diseases. 2024; 12(1).

PMID: 38248370 PMC: 10813899. DOI: 10.3390/diseases12010019.

Analysis of Pathogenic Bacteria Distribution and Related Factors in Recurrent Acute Cholangitis.

Li K, Hu X, Lu Q, Zhang H, Zhou J, Tian S Infect Drug Resist. 2023; 16:4729-4740.

PMID: 37492797 PMC: 10364819. DOI: 10.2147/IDR.S418752.

References

Pouch S, Satlin M . Carbapenem-resistant Enterobacteriaceae in special populations: Solid organ transplant recipients, stem cell transplant recipients, and patients with hematologic malignancies. Virulence. 2016; 8(4):391-402. PMC: 5477691. DOI: 10.1080/21505594.2016.1213472. View

Nordmann P, Poirel L . Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria. Clin Infect Dis. 2019; 69(Suppl 7):S521-S528. PMC: 6853758. DOI: 10.1093/cid/ciz824. View

Goodman K, Simner P, Tamma P, Milstone A . Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE). Expert Rev Anti Infect Ther. 2015; 14(1):95-108. DOI: 10.1586/14787210.2016.1106940. View

Warren D, Guth R, Coopersmith C, Merz L, Zack J, Fraser V . Epidemiology of methicillin-resistant Staphylococcus aureus colonization in a surgical intensive care unit. Infect Control Hosp Epidemiol. 2006; 27(10):1032-40. DOI: 10.1086/507919. View

Sexton M, Bower C, Jacob J . Risk factors for isolation of carbapenem-resistant Enterobacterales from normally sterile sites and urine. Am J Infect Control. 2021; 50(8):929-933. DOI: 10.1016/j.ajic.2021.12.007. View

AlEidan F, Alkhelaifi H, Alsenaid A, Alromaizan H, Alsalham F, Almutairi A . Incidence and risk factors of carbapenem-resistant infection in intensive care units: a matched case-control study. Expert Rev Anti Infect Ther. 2020; 19(3):393-398. DOI: 10.1080/14787210.2020.1822736. View

Sung Y, Lee J, Lee K, Lee K, Kang C . The clinical epidemiology and outcomes of bacteremic biliary tract infections caused by antimicrobial-resistant pathogens. Am J Gastroenterol. 2012; 107(3):473-83. DOI: 10.1038/ajg.2011.387. View

Chamieh A, El-Hajj G, Zmerli O, Afif C, Azar E . Carbapenem resistant organisms: A 9-year surveillance and trends at Saint George University Medical Center. J Infect Public Health. 2019; 13(12):2101-2106. DOI: 10.1016/j.jiph.2019.02.019. View

OHara L, Nguyen M, Calfee D, Miller L, Pineles L, Magder L . Risk factors for transmission of carbapenem-resistant Enterobacterales to healthcare personnel gloves and gowns in the USA. J Hosp Infect. 2020; 109:58-64. PMC: 8211026. DOI: 10.1016/j.jhin.2020.12.012. View

10.

Oka K, Matsumoto A, Tetsuka N, Morioka H, Iguchi M, Ishiguro N . Clinical characteristics and treatment outcomes of carbapenem-resistant Enterobacterales infections in Japan. J Glob Antimicrob Resist. 2022; 29:247-252. DOI: 10.1016/j.jgar.2022.04.004. View

11.

Aboelsoud M, Siddique O, Morales A, Seol Y, Al-Qadi M . Early biliary drainage is associated with favourable outcomes in critically-ill patients with acute cholangitis. Prz Gastroenterol. 2018; 13(1):16-21. PMC: 5894448. DOI: 10.5114/pg.2018.74557. View

12.

Mody L, Gibson K, Horcher A, Prenovost K, McNamara S, Foxman B . Prevalence of and risk factors for multidrug-resistant Acinetobacter baumannii colonization among high-risk nursing home residents. Infect Control Hosp Epidemiol. 2015; 36(10):1155-62. PMC: 4626246. DOI: 10.1017/ice.2015.143. View

13.

Tian S, Li K, Tang H, Peng Y, Xia L, Wang X . Clinical characteristics of Gram-negative and Gram-positive bacterial infection in acute cholangitis: a retrospective observational study. BMC Infect Dis. 2022; 22(1):269. PMC: 8935737. DOI: 10.1186/s12879-021-06964-1. View

14.

Brugnaro P, Fedeli U, Pellizzer G, Buonfrate D, Rassu M, Boldrin C . Clustering and risk factors of methicillin-resistant Staphylococcus aureus carriage in two Italian long-term care facilities. Infection. 2009; 37(3):216-21. DOI: 10.1007/s15010-008-8165-1. View

15.

Wu D, Chen C, Liu T, Jia Y, Wan Q, Peng J . Epidemiology, Susceptibility, and Risk Factors Associated with Mortality in Carbapenem-Resistant Gram-Negative Bacterial Infections Among Abdominal Solid Organ Transplant Recipients: A Retrospective Cohort Study. Infect Dis Ther. 2021; 10(1):559-573. PMC: 7954940. DOI: 10.1007/s40121-021-00411-z. View

16.

Wang Z, Guo Z, Feng H, Fu C, Zhao G, Ma K . Treatment of Donor-derived Carbapenem-resistant Klebsiella pneumoniae Infection after Renal Transplantation with Tigecycline and Extended-infusion Meropenem. Curr Med Sci. 2021; 41(4):770-776. DOI: 10.1007/s11596-021-2397-z. View

17.

Wang Z, Qian Y, Bai H, Yang J, Li X . Allograft hemorrhage as a manifestation of carbapenem-resistant Klebsiella pneumonia infection in kidney transplant recipients: Case series. Medicine (Baltimore). 2020; 99(13):e18982. PMC: 7220740. DOI: 10.1097/MD.0000000000018982. View

18.

Nucleo E, Caltagirone M, Mattioni Marchetti V, DAngelo R, Fogato E, Confalonieri M . Colonization of long-term care facility residents in three Italian Provinces by multidrug-resistant bacteria. Antimicrob Resist Infect Control. 2018; 7:33. PMC: 5839059. DOI: 10.1186/s13756-018-0326-0. View

19.

Moghnieh R, Abdallah D, Jadayel M, Zorkot W, El Masri H, Dib M . Epidemiology, risk factors, and prediction score of carbapenem resistance among inpatients colonized or infected with 3rd generation cephalosporin resistant Enterobacterales. Sci Rep. 2021; 11(1):14757. PMC: 8292374. DOI: 10.1038/s41598-021-94295-1. View

20.

Olalekan A, Onwugamba F, Iwalokun B, Mellmann A, Becker K, Schaumburg F . High proportion of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae among extended-spectrum β-lactamase-producers in Nigerian hospitals. J Glob Antimicrob Resist. 2019; 21:8-12. DOI: 10.1016/j.jgar.2019.09.007. View